Zurich, Switzerland
NCT Number: NCT01207843
Optimized Radiological Diagnosis of Hepatic Candidiasis During the Treatment of Acute Leukemias
Hepatic candidiasis is a frequent complication in patients receiving intensive chemotherapy for acute leukemia. Hepatic lesions may be detected by computerized tomographic (CT) scans, but there is no standardized CT protocol for the diagnosis and follow-up of hepatic candidiasis.
The investigators compared the size of the fungal lesions in the chest and abdomen CT. The current analysis aimed to increase the value of CT for the diagnosis and the follow-up of hepatic candidiasis in daily routine.
Looking for future studies?
Notify MeKey information
Conditions
Age range
16 year–80 year
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Chest and Abdomen CT with fungal lesion in patients with leukemia
Exclusion criteria
- Other liver pathologies
Treatment and study plan
Imaging
BehavioralCT image validation and lesion measurement, as well as comparison of different CT phases
Primary outcomes
-
The primary end-point was IFI according to the EORTC/MSG 2008 definitions and bacteraemia
Time frame: 2 Years
Sponsors and collaborators
Lead sponsor
University of Zurich
Other
Registry information
Official study title
Verbesserung Der Radiologischen Diagnose Von Hepatolienaler Candidiasis während Der Therapie Der Leukämie
Important dates
- Study start
- 2009
- Primary completion
- 2011
- Study completion
- 2013
- First posted
- Sep 23, 2010
- Registry last updated
- Aug 19, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
NCT00075803
Bone Marrow Diseases, Hematologic Diseases
Birmingham, Alabama, United States
View Trial DetailsSirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
NCT00589563
Blood Protein Disorders, Bone Marrow Diseases
Phoenix, Arizona, United States
View Trial DetailsCaspofungin Acetate in Treating Children With Fever and Neutropenia
NCT00020527
Agranulocytosis, Body Temperature Changes
Washington D.C., District of Columbia, United States
View Trial DetailsAntifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
NCT00002742
Blood Protein Disorders, Bone Marrow Diseases
Phoenix, Arizona, United States
View Trial Details